Abnova FISH probes for cancer research

Wednesday, 09 August, 2023 | Supplied by: Sapphire Bioscience

Abnova provides a collection of fluorescence in situ hybridisation (FISH) probes targeting various potential prognostic biomarkers for oncology. The company’s cytogenetic probes enable high hybridisation efficiency, ready for the rapid identification of chromosomal abnormalities — such as amplifications, translocation, fusion and splitting — that are frequently encountered across the genome.

Designed for the purpose of pinpointing DNA targets in cells and in tissues, the FISH probes will facilitate further research for lung adenocarcinoma, ovarian cancer, pancreatic cancer, prostate cancer and more.

Online: www.sapphirebioscience.com
Phone: 02 9698 2022
Related Products

Navinci Diagnostics Naveni CD8/MHC-I Atto647N proximity ligation assay (PLA) kit

The Naveni CD8/MHC-I Atto647N is an in situ proximity ligation assay kit for the detection of the...

Invent Biotechnologies Minute Single Cell Nuclei Kits

The Invent Biotechnologies Minute Single Cell Nuclei Kits use proprietary spin column-based...

MP Biomedicals MagBeads FastDNA MaxPure Kit for Feces and Fecal Preservation Solution

MP Biomedicals MagBeads FastDNA MaxPure Kit for Feces is a magnetic bead-based solution...

Content from other channels on our network

From compliance to circularity: three ways pharma manufacturers can rethink resource management

Tomago Aluminium smelter gets green investment

Stantec acquires Sydney-based consultancy

Researchers recover silver from end-of-life solar panels

Soft Low-E coated photovoltaic glass reduces energy demand

SPC Global expands its Aussie-made footprint across North Asia

foodpro wrap-up: the event welcomed over 10,000 visitors

interpack China to partner with AIP

Food and beverage businesses get ready for AI future

Nanoantibody technology to address aquaculture challenges

"Migrant worker exploitation" sees NSW aged care provider repay nearly $120K

A Day in the Life of a birth suite ANUM

Professor Andrea Driscoll MACN wins 2026 Nursing Trailblazers Award

Do new AI models reproduce gender and racial stereotypes in medicine?

Small decisions. System-wide impact: Where sustainability and healthcare operations meet

  • All content Copyright © 2026 Westwick-Farrow Pty Ltd